Ignite Creation Date:
2024-05-06 @ 2:00 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01942135
Status:
COMPLETED
Last Update Posted:
2024-04-04
First Post:
2013-09-10
Brief Title:
Palbociclib PD-0332991 Combined With Fulvestrant In Hormone Receptor HER2-Negative Metastatic Breast Cancer After Endocrine Failure PALOMA-3
Sponsor:
Pfizer
Organization:
Pfizer